Mersana Therapeutics, Inc.
MRSN
$0.3659
$0.00982.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -44.15% | -35.61% | -35.61% | -43.21% | -33.14% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -18.49% | -54.07% | -49.89% | -55.70% | -44.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -43.38% | -36.04% | -35.71% | -43.13% | -33.45% |
|
|
|||||
| Total Current Assets | -43.38% | -36.04% | -35.71% | -43.13% | -33.45% |
| Net Property, Plant & Equipment | -45.68% | -41.16% | -36.99% | -31.42% | -24.95% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 37.45% | 104.60% | 104.60% | 89.17% | -18.71% |
| Total Assets | -43.30% | -36.01% | -35.52% | -42.40% | -33.03% |
|
|
|||||
| Total Accounts Payable | 41.74% | -40.84% | -84.30% | -82.19% | -83.00% |
| Total Accrued Expenses | -17.12% | -9.05% | -25.88% | -46.87% | -51.96% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 88.02% | 199.36% | 384.89% | 296.26% | 201.48% |
| Total Finance Division Other Current Liabilities | -6.02% | -24.10% | 21.37% | 36.70% | -12.92% |
| Total Other Current Liabilities | -6.02% | -24.10% | 21.37% | 36.70% | -12.92% |
| Total Current Liabilities | 8.90% | -1.85% | 0.54% | -17.00% | -35.97% |
|
|
|||||
| Total Current Liabilities | 8.90% | -1.85% | 0.54% | -17.00% | -35.97% |
| Long-Term Debt | -60.69% | -52.70% | -44.35% | -32.02% | -19.62% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -94.61% | -75.01% | -62.14% | -44.35% | -38.56% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -16.31% | -18.22% | -24.79% | -23.32% | -20.38% |
| Total Liabilities | -15.87% | -18.49% | -20.04% | -22.83% | -26.53% |
|
|
|||||
| Common Stock & APIC | 1.72% | 2.64% | 2.73% | 2.74% | 12.72% |
| Retained Earnings | -8.75% | -8.37% | -9.25% | -13.69% | -18.96% |
| Treasury Stock & Other | -- | -9.09% | 2,400.00% | -44.90% | -850.00% |
| Total Common Equity | -210.30% | -125.77% | -97.99% | -90.62% | -56.47% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -210.30% | -125.77% | -97.99% | -90.62% | -56.47% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -210.30% | -125.77% | -97.99% | -90.62% | -56.47% |
|
|
|||||